Cargando…
Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China
OBJECTIVES: To investigate the prevalence and risk factors associated with multi-drug resistant tuberculosis (MDR–TB) in Dalian, China. METHODS: This was a retrospective review of data from patients attending a TB clinic in Dalian, China between 2012 and 2015. Demographic and drug susceptibility dat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805195/ https://www.ncbi.nlm.nih.gov/pubmed/28345426 http://dx.doi.org/10.1177/0300060516687429 |
_version_ | 1783298922822762496 |
---|---|
author | Lv, Xin-Tong Lu, Xi-Wei Shi, Xiao-Yan Zhou, Ling |
author_facet | Lv, Xin-Tong Lu, Xi-Wei Shi, Xiao-Yan Zhou, Ling |
author_sort | Lv, Xin-Tong |
collection | PubMed |
description | OBJECTIVES: To investigate the prevalence and risk factors associated with multi-drug resistant tuberculosis (MDR–TB) in Dalian, China. METHODS: This was a retrospective review of data from patients attending a TB clinic in Dalian, China between 2012 and 2015. Demographic and drug susceptibility data were retrieved from TB treatment cards. Univariate logistic analysis was used to assess the association between risk factors and MDR–TB. RESULTS: Among the 3552 patients who were smear positive for Mycobacterium tuberculosis (MTB), 2918 (82.2%) had positive MTB cultures and 1106 (31.1%) had isolates that showed resistance to at least one drug. The overall prevalence of MDR–TB was 10.1% (359/3552; 131/2261 [5.8%] newly diagnosed and 228/1291 [17.7%] previously treated patients). Importantly, 75 extensively drug-resistant TB isolates were detected from 25 newly treated and 50 previously treated patients. In total, 215 (6.1%) patients were infected with a poly-resistant strain of MTB. Previously treated patients and older patients were more likely to develop MDR–TB. CONCLUSIONS: The study showed a high prevalence of MDR–TB among the study population. History of previous TB treatment and older age were associated with MDR–TB. |
format | Online Article Text |
id | pubmed-5805195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58051952018-02-14 Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China Lv, Xin-Tong Lu, Xi-Wei Shi, Xiao-Yan Zhou, Ling J Int Med Res Special Issue: Healthcare-Associated Infections and Antimicrobial Resistance: Findings and Policy Implications OBJECTIVES: To investigate the prevalence and risk factors associated with multi-drug resistant tuberculosis (MDR–TB) in Dalian, China. METHODS: This was a retrospective review of data from patients attending a TB clinic in Dalian, China between 2012 and 2015. Demographic and drug susceptibility data were retrieved from TB treatment cards. Univariate logistic analysis was used to assess the association between risk factors and MDR–TB. RESULTS: Among the 3552 patients who were smear positive for Mycobacterium tuberculosis (MTB), 2918 (82.2%) had positive MTB cultures and 1106 (31.1%) had isolates that showed resistance to at least one drug. The overall prevalence of MDR–TB was 10.1% (359/3552; 131/2261 [5.8%] newly diagnosed and 228/1291 [17.7%] previously treated patients). Importantly, 75 extensively drug-resistant TB isolates were detected from 25 newly treated and 50 previously treated patients. In total, 215 (6.1%) patients were infected with a poly-resistant strain of MTB. Previously treated patients and older patients were more likely to develop MDR–TB. CONCLUSIONS: The study showed a high prevalence of MDR–TB among the study population. History of previous TB treatment and older age were associated with MDR–TB. SAGE Publications 2017-03-27 2017-12 /pmc/articles/PMC5805195/ /pubmed/28345426 http://dx.doi.org/10.1177/0300060516687429 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Special Issue: Healthcare-Associated Infections and Antimicrobial Resistance: Findings and Policy Implications Lv, Xin-Tong Lu, Xi-Wei Shi, Xiao-Yan Zhou, Ling Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China |
title | Prevalence and risk factors of multi-drug resistant tuberculosis in
Dalian, China |
title_full | Prevalence and risk factors of multi-drug resistant tuberculosis in
Dalian, China |
title_fullStr | Prevalence and risk factors of multi-drug resistant tuberculosis in
Dalian, China |
title_full_unstemmed | Prevalence and risk factors of multi-drug resistant tuberculosis in
Dalian, China |
title_short | Prevalence and risk factors of multi-drug resistant tuberculosis in
Dalian, China |
title_sort | prevalence and risk factors of multi-drug resistant tuberculosis in
dalian, china |
topic | Special Issue: Healthcare-Associated Infections and Antimicrobial Resistance: Findings and Policy Implications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805195/ https://www.ncbi.nlm.nih.gov/pubmed/28345426 http://dx.doi.org/10.1177/0300060516687429 |
work_keys_str_mv | AT lvxintong prevalenceandriskfactorsofmultidrugresistanttuberculosisindalianchina AT luxiwei prevalenceandriskfactorsofmultidrugresistanttuberculosisindalianchina AT shixiaoyan prevalenceandriskfactorsofmultidrugresistanttuberculosisindalianchina AT zhouling prevalenceandriskfactorsofmultidrugresistanttuberculosisindalianchina |